Skip to content

Down Syndrome, Physical Activity and Sleep Apnea

Down Syndrome, Physical Activity and Sleep Apnea

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06061562
Acronym
TAPAS
Enrollment
50
Registered
2023-09-29
Start date
2024-01-11
Completion date
2026-12-31
Last updated
2024-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Down Syndrome

Keywords

Down syndrome, sleep disorders, Apnea, physical activity, neurocognition, autonomic nervous system

Brief summary

To realize a sleep phenotyping in a population with Down syndrome, its determinants, and the consequences of these disorders, with a specific focus on sleep apnea syndrome.

Detailed description

Sleep disorders are widely observed in the Down's syndrome population, due to a number of risk factors, and can become established in early childhood. Diagnosis of sleep disorders in Down's syndrome is difficult and often delayed, which can contribute to poor health in children with Down's syndrome. Phenotyping sleep characteristics in this Down Syndrome population will enable early identification of the consequences of these disorders, with a specific focus on sleep apnea syndrome, whose origin is multisystemic.

Interventions

None listed

Sponsors

University Hospital, Grenoble
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Total autosomal trisomy caused by the presence of a third copy (partial or total) of chromosome 21

Exclusion criteria

* People with abnormal electrocardiographic tracings, * Existence of heart failure or cardiovascular disease, as determined by any abnormalities in cardiovascular adaptations to exercise. * Existence of a declared or uncontrolled progressive disease. * pregnant or breast-feeding women.

Design outcomes

Primary

MeasureTime frameDescription
phenotyping of sleep in a population with Down's syndrome, its determinants, and the consequences of these disorders, with a specific focus on sleep apnea syndrome, whose origin is multisystemicVisite 2: 2 nightsDiagnosis of Sleep Apnea Syndrome using calculation of apnea hypopnea index (AHI)\>15 events/h

Secondary

MeasureTime frameDescription
Sleep-disordered breathing associated with dysautonomiaVisite 2: 1 nightPolysomnography
Sleep-disordered breathing associated with specific abnormalities of the biological work-upVisite 1: the morning before the physical activityBiological disturbances will be assessed by differences in thyroid function, and other biological variables (NFS, lipid and hormone levels, iron levels) in comparison with standards. This biological assessment is obtained by blood sampling.
Sleep-disordered breathing associated with a specific cranial structureDay 0The existence of cranial anatomical variations, in particular anomalies specific to the oral sphere (modification of the gonia angle (in degrees), and prognatism (in cm)) will be investigated by cephalometry.
Sleep-disordered breathing associated with inadequate physical activityDay 0 and visite 1Abnormalities in the physiological response to exercise (VO2 (in mL/kg/min) compared with the predicted value) will be investigated and linked to the level of physical activity measured by questionnaires (scores).
Sleep-disordered breathing associated with specific neurobehavioral disordersDay 0A neurobehavioral profile assessment will be carried out using several tests, in order to verify the possible impact of TdS on cognitive function: * Intelligence quotient (Wechsler scale), if not previously performed (score) * Stroop task (inhibitory control) (score) * Reaction time using a light device (seconds) * Ability to perform a double cognitive-motor task, (score) * BRIEF questionnaire (to explore executive function) (score) * ADHD rating scale (to explore signs of attention deficit/hyperactivity disorder). (score)

Countries

France

Contacts

Primary ContactVeronique BRICOUT
VBricout@chu-grenoble.fr0476767226

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026